Breast Augmentation Global Market Report 2025

The breast augmentation market size has grown rapidly in recent years. It will grow from $1.4 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to the rising demand for cosmetic procedures, increasing disposable incomes, greater awareness of aesthetic treatments, the growing influence of social media, and the expansion of medical tourism.

The breast augmentation market size is expected to see rapid growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to the increasing prevalence of breast reconstruction post-mastectomy, a rising preference for outpatient procedures, a growing female workforce, expanding global urbanization, greater awareness of breast health, and increasing demand for natural-looking results. Key trends expected during this period include advancements in implant technology, the development of safer implant materials, progress in 3D imaging for surgical planning, the creation of lightweight implants, and the integration of artificial intelligence in surgical planning.

The increasing expenditure on aesthetic procedures is expected to drive the growth of the breast augmentation market. Spending on aesthetic procedures refers to financial investments in cosmetic treatments aimed at enhancing appearance, rejuvenating skin, or achieving better body balance. The rise in spending is fueled by factors such as increasing beauty consciousness, advancements in minimally invasive techniques, higher disposable incomes, and greater acceptance of cosmetic enhancements. Increased investment in aesthetic procedures grants access to premium implants and state-of-the-art minimally invasive techniques, ensuring personalized treatments that enhance safety, aesthetics, and post-surgical recovery. For instance, in August 2023, The Aesthetic Society, a US-based organization dedicated to advancing cosmetic surgery, reported that Americans spent over $11.8 billion on aesthetic procedures in 2022, reflecting a 2% increase from the previous year. As a result, the growing expenditure on aesthetic procedures is driving the expansion of the breast augmentation market.

Leading companies in the breast augmentation market are focusing on developing advanced silicone gel-filled implants to enhance safety and improve aesthetic outcomes. Silicone gel-filled implants feature a silicone outer shell and a cohesive silicone gel interior designed to mimic the natural texture and movement of breast tissue. For example, in December 2024, Mentor Worldwide LLC, a US-based medical device company, announced that the U.S. Food and Drug Administration (FDA) had approved the MENTOR and MemoryGel Enhance Breast Implant, specifically designed for breast reconstruction in women with larger cup sizes. This innovative implant line offers sizes ranging from 930 cc to 1445 cc, catering to post-mastectomy patients undergoing both primary and revision reconstruction surgeries. Mentor plans to commercially launch these implants in the U.S. by mid-2025, marking a significant advancement in personalized breast reconstruction options.

In October 2023, GC Aesthetics, an Ireland-based manufacturer of silicone breast implants, partnered with Bimini Health Tech to enhance global breast reconstruction solutions. This collaboration led to the formation of OPALINE Aesthetics, combining expertise in breast implants with innovative healthcare solutions. Through this partnership, GC Aesthetics will expand Bimini’s technologies globally (excluding the U.S. and Canada), while Bimini will introduce select GC Aesthetics products in the U.S. This strategic alliance enhances worldwide access to advanced breast reconstruction options. Bimini Health Tech is a US-based company specializing in aesthetic and reconstructive healthcare solutions.

Major players in the breast augmentation market are Johnson & Johnson Private Limited, Allergan Aesthetics, Establishment Labs Holdings Inc., Silimed, Sientra Inc., GC Aesthetics Inc., Hans Biomed Corporation, Crisalix S.A, Polytech Health & Aesthetics GmbH, Sebbin, Arion Laboratories Inc., Shanghai Winner Plastic Surgery Products Co. Ltd., CEREPLAS company, Keller Medical Inc., Nagor Limited, Bimini Health Tech, Triton Medical Services Pvt. Ltd., Prayasta, Guangzhou Wanhe Plastic Materials Co. Ltd., and Shanghai Kangning Medical Device Co. Ltd.

North America was the largest region in the breast augmentation market in 2024. The regions covered in breast augmentation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the breast augmentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Breast augmentation, or augmentation mammoplasty, is a surgical procedure aimed at enhancing breast size, shape, or fullness through implants or fat transfer. It helps restore breast volume lost due to pregnancy, weight loss, or aging, improving body proportions and boosting self-confidence.

The primary product types for breast augmentation include silicone breast implants and saline breast implants. Silicone breast implants, filled with silicone gel, are widely used for augmentation and reconstruction due to their natural feel and shape. They come in various shapes, such as round and anatomical, and are used in multiple procedures, including inframammary fold, trans-axillary, periareolar, and trans-umbilical techniques. Breast augmentation is applied in both reconstructive and cosmetic surgery and is utilized by various end users, including hospitals, cosmetology clinics, and ambulatory surgical centers.

The breast augmentation market research report is one of a series of new reports that provides breast augmentation market statistics, including the breast augmentation industry global market size, regional shares, competitors with the breast augmentation market share, detailed breast augmentation market segments, market trends, and opportunities, and any further data you may need to thrive in the breast augmentation industry. This breast augmentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The breast augmentation market consists of revenues earned by entities by providing services such as fat transfer augmentation, revision surgery, and implant placement. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast augmentation market also includes sales of surgical instruments and devices, scar treatment products, compression garments and surgical bras, and fat transfer kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.